Constructing the world's newest nuclear medicine manufacturing facility
Principal Technical Consultant Michael Druce shares some personal insights on the design and construction of ANSTO's nuclear medicine facility.
Showing 121 - 140 of 167 results
Principal Technical Consultant Michael Druce shares some personal insights on the design and construction of ANSTO's nuclear medicine facility.
The Medium Energy- X-ray Absorption Spectroscopy beamlines will provide access to XANES and EXAFS data from a bending magnet source, optimised for cutting-edge applications in biological, agricultural and environmental science in an energy range that is not currently available at the Australia Synchrotron.
ANSTO groundwater experts have collaborated with the NSW Department of Planning, Industry and Environment on a comprehensive survey of groundwater resources in the state.
The Advanced Diffraction and Scattering beamlines (ADS-1 and ADS-2) are two independently operating, experimentally flexible beamlines that will use high-energy X-ray diffraction and imaging to characterise the structures of new materials and minerals.
ANSTO's Melbourne location is home to the ANSTO-owned and operated Australian Synchrotron. The Synchrotron is one of the Australia's most significant pieces of scientific infrastructure.
ANSTO’s user office in Melbourne offers access to the Australian Synchrotron, a world-class research facility with over 4,000 user visits per year. ANSTO seeks collaboration and partnerships with research organisations, scientific users and commercial users.
ANSTO has agreed to participate in an Australian trial of a review of research infrastructure access proposals in which applicants remain anonymous to aid the removal of structural barriers to the career progression of Women in STEM.
The Infrared microspectroscopy microscopes can record spectra from a range of different samples; from thin microtomed sections to polished blocks and embedded particles. This section highlights the types of samples that can be analysed using the IRM beamline
Australia’s nuclear agency ANSTO is continuing to lead planning efforts to repatriate what is called a TN-81 cask of intermediate-level radioactive from the United Kingdom in 2022.
ANSTO provides eduroam services for partnering institutions in Australia and around the world.
The ARC Centre of Excellence (CoE) for Green Electrochemical Transformation of Carbon Dioxide, GETCO2, will support innovative approaches to carbon capture.
nandin is ANSTO’s Innovation Centre where science and technology entrepreneurs, startups and graduates meet industry expertise to experiment, co-create, innovate, and commercialise, creating new jobs in the high-growth industries of tomorrow.
ANSTO is committed to minimising the environmental impact of its activities and to implementing strategies which have a positive effect on the environment. The ANSTO Work Health Safety and Executive Committee oversees this process.
ANSTO plays a leading role in measuring and characterising fine particles from a range of locations around Australia and internationally.
Innovative medical device Rhenium-SCT® therapy for non-melanoma skin cancer is now available in Australia
CORIS360 delivers fast, accurate radiation detection and imaging, making invisible radiation visible to improve safety and decision making in radioactive environments.